NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $221,000 | +7.3% | 2,341 | -1.3% | 0.01% | 0.0% |
| Q3 2020 | $206,000 | -47.8% | 2,371 | -47.6% | 0.01% | -54.5% |
| Q2 2020 | $395,000 | -4.6% | 4,521 | -10.0% | 0.02% | -18.5% |
| Q1 2020 | $414,000 | -12.3% | 5,021 | +0.7% | 0.03% | +8.0% |
| Q4 2019 | $472,000 | +1.5% | 4,986 | -6.8% | 0.02% | -7.4% |
| Q3 2019 | $465,000 | +17.1% | 5,347 | +23.0% | 0.03% | +17.4% |
| Q2 2019 | $397,000 | -6.6% | 4,347 | -1.7% | 0.02% | -11.5% |
| Q1 2019 | $425,000 | +12.1% | 4,420 | 0.0% | 0.03% | -3.7% |
| Q4 2018 | $379,000 | -0.5% | 4,420 | -0.0% | 0.03% | +17.4% |
| Q3 2018 | $381,000 | -48.1% | 4,422 | -52.8% | 0.02% | -4.2% |
| Q2 2018 | $734,000 | +88.2% | 9,378 | +94.2% | 0.02% | -7.7% |
| Q1 2018 | $390,000 | -7.4% | 4,829 | -3.6% | 0.03% | -10.3% |
| Q4 2017 | $421,000 | +75.4% | 5,010 | +79.2% | 0.03% | +20.8% |
| Q4 2015 | $240,000 | +15.9% | 2,795 | +24.3% | 0.02% | +9.1% |
| Q3 2015 | $207,000 | – | 2,249 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |